SandozBiomanufacturingSandoz breaks ground on US$440m biosimilar...Biosimilar major Sandoz has started construction of an additional US$440m biosimilar facility near Ljubljana and it set to expand its investment footprint in Slovenia by US$1.1bn. more ➔
Unnatural Products IncPartnershipArgenx and Unnatural Products ink US$1.5bn...California oral macrocyclic peptide specialist Unnatural Products, Inc. and Dutch-Belgian Argenx SE have formed a multi-target research collaboration aimed at developing oral macrocyclic peptide drugs … more ➔
Vetter Pharma International GmbHCDMOVetter invests US$285m in Chicago producti...CDMO and filled syringe specialist Vetter has broken the ground for a new clinical site construction in the greater Chicago area that is expected to be ready for early clinical filling by the end of … more ➔
HeiQ/AeoniQ, RenewcellbioeconomyAltri acquires majority stake in fibre spe...Portuguese fibre producer Altri SGPS S.A.has signed an agreement to acquire a majority interest in Swiss clean technology company AeoniQ to support the commercial-scale development of the first fully … more ➔
adobe stock photos - Sergii Figurnyi NGTParliament halts trilogue talks on New Gen...Final negotiations on proposed EU regulations for plants developed through genetic precision breeding have been delayed, following opposition from a group of MEPs in the European Parliament’s ENVI … more ➔
Laverock TherapeuticsFinancingLaverock Therapeutics bags additional £6....British targeted gene silencing specialist Laverock Therapeutics Ltd has expanded its seed funding to £20m by a new financing round led by xx and xx. The company said it will use the funds to…l more ➔
Medicines for EuropeRegulatoryEU Commissioner Várhelyi revives Biotech...In a surprise move, Health Commissioner Oliver Várhelyi announced at the Medicines for Europe Annual Conference that the EU Biotech Act will go ahead this year, reversing its provious delay from Q3 … more ➔
www.gov.ukUpscalingUK to invest £380m in Engineering BiologyThe UK government has unveiled a new industrial strategy that includes a commitment to invest £380m in engineering biology. The package comprises an initial £196m for research and development, and … more ➔
Max Kratzer / PlectonicAI-guided drug developmentSonrai and Plectonic Biotech partner to ad...Under a new partnership, Plectonic Biotech will use Sonrai’s AI-powered multi-omics platform to speed up development of its Logybody cancer treatment technology. The approach aims to cut side effects … more ➔
Alexandros MICHAILIDISGreen Claims DirectiveItaly and Germany block central green deal...The European Commission has scraped a key piece of Green Deal legislation following political shifts within the European Parliament. The move came after Italy, governed by a far-right administration … more ➔
Sandoz
Unnatural Products Inc
Vetter Pharma International GmbH
HeiQ/AeoniQ, Renewcell
adobe stock photos - Sergii Figurnyi 
Laverock Therapeutics
Medicines for Europe
www.gov.uk
Max Kratzer / Plectonic
Alexandros MICHAILIDIS